|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
ϵͳ�Ժ���Ǵ� |
|
����ѧ���� |
| ��������������� | |
|
�½� |
|
�·� |
| PubMed | |
|
Article by |
|
Article by |
ϵͳ�Ժ���Ǵ������Ƽ����Ƶ��о���չ
�½�, �·�
������ҽ��ѧ����ҽԺƤ���� ���� 400038
ϵͳ�Ժ���Ǵ���һ�ֳ������Ͷ��,Ŀǰ��ȱ����ȫ����Ч�����Ʒ�������������������ѧ�ķ�չʹ�����Ƽ�������������ϵͳ�Ժ���Ǵ���Ϊ����,�־���һ����Ľ�չ��һ���ܡ�
[2] Mohan C,Shi Y,Laman JD,et al.Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.J Immunol,1995,154(3):1470-1480.
[3] Finck BK,Linsley PS,Wofsy D.Treatment of murine lupus with CTLA4Ig.Science,1994,265(5176):1225-1227.
[4] Sfikakis PP,Via CS.Expression of CD28,CTLA4,CD80,and CD86molecules in patients with autoimmune rheumatic diseases:implications for immunotherapy.Clin Immunol Immunopathol,1997,83(3):195-198.
[5] Liblau R,Tisch R,Bercovici N,et al.Systemic antigen in the treatment of T-cell-mediated autoimmune diseases.Immunol Today,1997,18(12):599-604.
[6] Zimmerman R,Radhakrishnan J,Valeri A,et al.Advances in the treatment of lupus nephritis.Annu Rev Med,2001,52:63-78.
[7] Strand V,Lee M.Intravenous immunoglobulin in the treatment of autoimmune disease.In Strand V,Scott DL,Simon LS:Novel therapeutic agents for the treatment of autoimmune disease.New York:Dekker,1997.235-256.
[8] Weisman MH,Bluestein HG,Bemer CM,et al.Reduction in circulating dsDNA antibody titer after administration of LJP 394.J Rheumatol,1997,24(2):314-318.
[9] Tumlin JA.Lupus nephritis:novel immunosuppressive modalities and future directions.Semin Nephrol,1999,19(1):67-76.
[10] Pan CQ,Dodge TH,Baker DL,et al.Improved potency of hyperactive and actin-resistant human DNase I variants for treatment of cystic fibrosis and systemic lupus erythematosus.J Biol Chem,1998,273(29):18374-18381.
[11] Balow JE,Boumpas DT,Austin HA 3rd.New prospects for treatment of lupus nephritis.Semin Nephrol,2000,20(1):32-39.
[12] Evans CH,Whalen JD,Evans CH,et al.Gene therapy in autoimmune diseases.Ann Rheum Dis,1998,57(3):125-127.
[13] Hong NM,Masuko-Hongo K,Sasakawa H,et al.Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice(gld) by Fas-ligand gene transfer.J Autoimmun,1998,11(4):301-307.
[14] Chuzhin Y,Reddy B,Budhai L,et al.Prolonged survival in murine SLE by adenoviral mediated CTLA4Ig gene transfer.Arthritis Rheum,1998,41(Suppl):S140-146.
[15] Brodsky RA,Petri M,Jones RJ.Hematopoietic stem cell transplantation for systemic lupus erythematosus.Rheum Dis Clin North Am,2000,26(2):377-387.
[16] Traynor AE,Schroeder J,Rosa RM,et al.Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stemcell transplantation:a phase I study.Lancet,2000,356(9231):701-707.
[17] Tyndall A.Immunoablation and haemopoietic stem cell transplantation for severe autoimmune disease with special reference to systemic lupus erythematosus.Lupus,2001,10(3):214-215.